8th Apr 2021 15:57
Hutchison China Meditech Ltd - Hong-Kong-based pharmaceutical company - Agrees for the issuance of USD100 million of shares at a price of USD30.5 per American depositary share via a private placement to funds affiliated with Baring Private Equity Asia. The company says it will receive all proceeds from this private placement of the 3.3 million American depositary shares, which will fund ongoing research and clinical development and support the further growth of its commercialization capabilities both in China and globally.
Current stock price: 418.50 pence, up 2.2% on Thursday
Year-to-date change: down 9.0%
By Evelina Grecenko; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Hutchmed